LIVEPERSON INC (LPSN)

US5381461012 - Common Stock

0.4951  +0.03 (+6.91%)

Premarket: 0.5045 +0.01 (+1.9%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LPSN. LPSN was compared to 276 industry peers in the Software industry. LPSN may be in some trouble as it scores bad on both profitability and health. LPSN is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

LPSN had negative earnings in the past year.
In the past year LPSN has reported a negative cash flow from operations.
LPSN had negative earnings in each of the past 5 years.
In multiple years LPSN reported negative operating cash flow during the last 5 years.

1.2 Ratios

LPSN's Return On Assets of -12.02% is in line compared to the rest of the industry. LPSN outperforms 42.70% of its industry peers.
The Return On Equity of LPSN (-208.62%) is worse than 81.39% of its industry peers.
Industry RankSector Rank
ROA -12.02%
ROE -208.62%
ROIC N/A
ROA(3y)-14.43%
ROA(5y)-14.54%
ROE(3y)-191.95%
ROE(5y)-136.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LPSN has a Gross Margin (64.48%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of LPSN has declined.
The Profit Margin and Operating Margin are not available for LPSN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.18%
GM growth 5Y-2.99%

1

2. Health

2.1 Basic Checks

LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
LPSN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LPSN has been increased compared to 5 years ago.
LPSN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.19, we must say that LPSN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.19, LPSN is doing worse than 76.64% of the companies in the same industry.
A Debt/Equity ratio of 10.63 is on the high side and indicates that LPSN has dependencies on debt financing.
The Debt to Equity ratio of LPSN (10.63) is worse than 86.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.63
Debt/FCF N/A
Altman-Z -1.19
ROIC/WACCN/A
WACC1.14%

2.3 Liquidity

A Current Ratio of 1.20 indicates that LPSN should not have too much problems paying its short term obligations.
LPSN's Current ratio of 1.20 is on the low side compared to the rest of the industry. LPSN is outperformed by 67.15% of its industry peers.
A Quick Ratio of 1.20 indicates that LPSN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.20, LPSN is not doing good in the industry: 64.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2

3

3. Growth

3.1 Past

The earnings per share for LPSN have decreased strongly by -16.51% in the last year.
Looking at the last year, LPSN shows a very negative growth in Revenue. The Revenue has decreased by -21.93% in the last year.
The Revenue has been growing by 9.98% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.51%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q12.73%
Revenue 1Y (TTM)-21.93%
Revenue growth 3Y3.12%
Revenue growth 5Y9.98%
Revenue growth Q2Q-22.07%

3.2 Future

Based on estimates for the next years, LPSN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.47% on average per year.
LPSN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -12.47% yearly.
EPS Next Y32.54%
EPS Next 2Y25.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-23.16%
Revenue Next 2Y-12.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

LPSN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LPSN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

LPSN's earnings are expected to grow with 25.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LPSN!.
Industry RankSector Rank
Dividend Yield N/A

LIVEPERSON INC

NASDAQ:LPSN (4/23/2024, 7:10:57 PM)

Premarket: 0.5045 +0.01 (+1.9%)

0.4951

+0.03 (+6.91%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap43.62M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.02%
ROE -208.62%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 64.49%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 10.63
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-16.51%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y32.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-21.93%
Revenue growth 3Y3.12%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y